Ultrahuman’s $70M Round Says the $365M Bet Is Bigger Than a Smart Ring
$70 million is an absurd amount to raise for a ring—unless the ring stops being jewellery and becomes the computer that knows your body better than your phone does.
$70 million is an absurd amount to raise for a ring—unless the ring stops being jewellery and becomes the computer that knows your body better than your phone does.
That is the real bet behind Ultrahuman’s new $70 million financing. Not another sleep score. Not another smug notification telling you to drink water. The Bengaluru startup is trying to turn a tiny health wearable into a personal computing platform, and Qualcomm Ventures has decided that is worth backing.
Ultrahuman just raised $70M to escape the smart-ring box
On September 3, Ultrahuman announced a $70 million round involving Qualcomm Ventures, Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners and Alteria Capital. The package comprises $65 million in primary equity and $5 million in debt. TechCrunch reported the round values the company at $365 million—roughly triple its reported $120 million valuation in 2023. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
That valuation is not a vote of confidence in a fancier Fitbit. It is a wager that the next meaningful computing interface may be something you barely notice wearing.
Ultrahuman co-founder and CEO Mohit Kumar says the company is developing a Qualcomm-powered ring while continuing to use Nordic Semiconductor chips. The point of extra processing capacity is straightforward: move more software and algorithms onto the ring itself rather than making the device a dumb sensor feeding a phone and cloud service. The company is also planning software features for current Ring Air and Ring Pro devices, including AI interactions, game-controller functions and tools for third-party developers. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
Most hardware founders get trapped selling a feature. Better battery life. Nicer materials. One more health metric nobody asked for. Ultrahuman is trying to sell an operating position instead: the place where a person’s biological data, physical actions and software services meet.
That is a much bigger market. It is also much harder to pull off.
The numbers matter because hardware is brutal
There is one reason this story deserves more attention than the usual venture-capital confetti: Ultrahuman appears to have actual commercial momentum.
The company says it is operating at a $140 million annual revenue run rate, up roughly 45% from a year earlier, and expects to reach a $200 million run rate by January 2027. It says it has sold about 800,000 rings, compared with around 700,000 in February. About 12% of users pay for PowerPlugs, its subscription software features. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
Those are company-reported figures, not audited public-market disclosures, so treat them accordingly. Still, they point to something rare: a wearable company that is not simply buying growth with celebrity ads and hoping a public listing saves it later.
Ultrahuman began in 2019 with continuous glucose monitoring before smart rings became the core business. It has since added blood testing and environmental sensing. That product sprawl could easily become a mess. But it also gives the company a credible shot at building a broader health-data relationship with customers, rather than living or dying by one ring upgrade every couple of years. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
Here is the important distinction: hardware revenue is nice; recurring data and services revenue is where the real economics live. A ring sold once is a transaction. A customer who trusts the platform with ongoing health information, pays for useful software, takes tests and remains in the ecosystem is a business.
Every founder building a physical product should tattoo that difference on their forehead.
Qualcomm and Labcorp are not just logos on a press release
The investor list tells you more than the press release does.
Qualcomm Ventures brings access to silicon, engineering expertise and a strategic incentive to put more capable computing into small devices. Labcorp brings something different: a route toward more serious health and diagnostics applications. Ultrahuman says it is exploring ways to combine signals captured by the ring with blood-test data to identify risks relating to cardiovascular health, fertility and ageing. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
That does not mean the ring has magically become a medical device. It has not. And founders should be careful here: the graveyard is full of consumer-health companies that confused a promising correlation with a clinically useful product.
But the direction is sensible. Consumer wearables have spent years measuring proxies: sleep, movement, resting heart rate, temperature trends. The next leap is not collecting even more data. It is connecting continuous data with more meaningful reference points, then delivering an answer a normal person can act on.
That is where the Labcorp relationship matters. If Ultrahuman can make a ring genuinely useful before a health event becomes a doctor’s appointment, it moves from lifestyle accessory into infrastructure for personal health decisions. That is a far more defensible place to be.
The overlooked problem: a ring is a terrible computer—until it is not
Let’s be honest. The idea of playing games or controlling software with a ring sounds a bit like one of those demos that gets applause at a conference and disappears six months later.
A ring has almost no screen, tiny battery capacity and limited space for sensors and processors. The constraints are savage. A phone already does everything. A smartwatch is already on your body. Why on earth does anyone need another device?
Because the best interface is often the one that gets out of the way.
A ring sits on a finger, close to useful physiological signals and naturally positioned for gestures. It can be worn while sleeping, training, eating, working or going out. A watch is visible, distracting and often removed. A phone is powerful but usually somewhere else. Glasses make people look as if they are auditioning for a bad science-fiction film.
If Ultrahuman can make a ring a precise input device while retaining the trust customers place in it for health data, it could have a genuinely differentiated interface. That is a massive “if”, by the way. But it is the right if.
The uncomfortable truth for founders is that most so-called AI hardware is currently software theatre glued to an expensive object. It talks, summarises and occasionally gets facts wrong in a new form factor. Ultrahuman’s more interesting opportunity is not stuffing a chatbot into jewellery. It is using a device’s unique position on the body to create experiences a laptop or phone cannot replicate.
Oura shows why distribution and defensibility still matter
Ultrahuman is not entering an empty field. Oura is the obvious rival, and Ultrahuman’s U.S. business has already felt the pain of competition beyond product reviews.
TechCrunch reported that Ultrahuman had to stop selling its Ring Air in the U.S. for much of the past year amid a patent dispute with Oura. It returned with the redesigned Ring Pro. Kumar says the U.S. now accounts for about 45% of revenue this quarter, while India contributes about 11%, and that U.S. demand for the Ring Pro is running at 18 to 20 times available supply. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
There is a lesson here that founders, particularly software founders, tend to learn too late: product is not the whole game. Intellectual property, manufacturing capacity, distribution, regulation and customer trust all become lethal when a category starts working.
Ultrahuman says it expects to regain prior U.S. sales volumes next quarter and aims to triple those volumes over the following four quarters as supply expands. It is also investing in physical retail touchpoints in markets including India and the UAE. ([techcrunch.com](https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/?utm_source=openai))
That may look unfashionable to the spreadsheet crowd. It should not. Hardware is tactile. Health is personal. A customer deciding whether to wear a ring every day may need to touch it, try it and ask a real person a question. The internet did not kill retail; it just killed lazy retail.
The contrarian view: Ultrahuman should avoid chasing every use case
The danger is obvious. A ring can be a health tracker, car key, mouse, controller, AI interface, fertility tool, blood-test companion and developer platform. Brilliant. It can also become a confused junk drawer sitting on somebody’s finger.
The company should resist the temptation to prove it can do everything. The best path is boring in the best possible way: own one painful, frequent and valuable health decision first. Make the insight undeniably useful. Build trust. Then expand.
I have seen this while building Agave Finder: when you have a big platform ambition, every adjacent feature looks clever. Most are distractions. The winning product is usually the one that makes a specific customer decision dramatically easier before it tries to become an ecosystem.
For Ultrahuman, the moat will not be a gesture-controlled game. It will be whether users believe its data helps them make better decisions about sleep, training, recovery, metabolic health or clinical follow-up—and whether that trust compounds over years.
What this means for you
If you are a founder, do not copy Ultrahuman by raising $70 million or adding “AI” to your hardware deck. Copy the useful bits.
First, build around a behaviour, not a gadget. A product earns a place in someone’s life by solving a repeat problem. Ultrahuman’s opportunity is not the titanium ring. It is the daily relationship with a customer’s health.
Second, use strategic investors for unfair advantages, not vanity. Qualcomm may help with silicon and product capability. Labcorp may help with diagnostics credibility and distribution. The right investor should shorten the distance between you and something hard to build.
Third, respect the ugly parts of scale. Supply, patents, regulation, retail and support are not admin work. They are the business when you sell atoms rather than pixels.
And if you are an investor or operator, watch what happens next. The $365 million valuation is not the story. The story is whether Ultrahuman can convert a growing ring business into trusted, recurring health infrastructure before a larger rival, a platform giant or its own ambition gets in the way.
That is the bet. Not a better ring. A new place for computing to live.